Lijing Yao

Lijing Yao is currently the Director of Bioinformatics at ENDPOINT HEALTH. With a background in genetic molecular cellular biology, Lijing has over a decade of experience in the field. Prior to ENDPOINT HEALTH, Lijing held positions at HypaHub, Inc. and Roche Molecular Systems, where they focused on bioinformatics and research. Lijing's research primarily revolves around understanding enhancers and their role in gene expression regulation, particularly in tumors. Through their roles in various companies and as a research assistant at the University of Southern California, Lijing has honed their expertise in bioinformatics and continues to make significant contributions to the field.